Constraints on publication rights in industry-initiated clinical trials.

Constraints on publication rights in industry-initiated clinical trials.

Bibliographic Details
Main Authors:	Gøtzsche, P, Hróbjartsson, A, Johansen, H, Haahr, M, Altman, D, Chan, A
Format:	Journal article
Language:	English
Published:	2006

Similar Items

Ghost authorship in industry-initiated randomised trials.
by: Gøtzsche, P, et al.
Published: (2007)

Reporting on blinding in trial protocols and corresponding publications was often inadequate but rarely contradictory.
by: Hróbjartsson, A, et al.
Published: (2009)

Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles.
by: Chan, A, et al.
Published: (2004)

Videnskabelig uredelighed
by: Gøtzsche, P, et al.
Published: (2009)

Kontakt til udvalgene for videnskabelig uredelighed er det logiske skridt: Svar
by: Gøtzsche, P, et al.
Published: (2009)

Discrepancies in sample size calculations and data analyses reported in randomised trials: comparison of publications with protocols.
by: Chan, A, et al.
Published: (2008)

Comparison of descriptions of allocation concealment in trial protocols and the published reports: cohort study.
by: Pildal, J, et al.
Published: (2005)

Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials.
by: Pildal, J, et al.
Published: (2007)

SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials.
by: Chan, A, et al.
Published: (2013)

Conflicts of interest at medical journals: the influence of industry-supported randomised trials on journal impact factors and revenue - cohort study.
by: Andreas Lundh, et al.
Published: (2010-10-01)

ASSESSING RISK OF BIAS IN RANDOMISED CLINICAL TRIALS INCLUDED IN COCHRANE REVIEWS: THE WHY IS EASY, THE HOW IS A CHALLENGE
by: Hrobjartsson, A, et al.
Published: (2013)

SPIRIT 2013 statement: defining standard protocol items for clinical trials.
by: Chan, A, et al.
Published: (2013)

WHO clinical trials initiative to protect the public

Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authors.
by: Chan, A, et al.
Published: (2005)

Portuguese Authorship in Published Clinical Trials: Differences in Industry and Investigator Initiated Trials
by: Maria Pinheiro Andrade, et al.
Published: (2021-11-01)

The role of Clinical Trial Units in investigator- and industry-initiated research projects
by: Belinda von Niederhäusern, et al.
Published: (2015-06-01)

Fungal infection-related mortality versus total mortality as an outcome in trials of antifungal agents
by: Gøtzsche Peter C, et al.
Published: (2006-08-01)

Better reporting of harms in randomized trials: an extension of the CONSORT statement.
by: Ioannidis, J, et al.
Published: (2004)

A review of the methodology and reporting of multi-arm, parallel group, randomised clinical trials
by: Juszczak, E, et al.
Published: (2003)

The revised CONSORT statement for reporting randomized trials: explanation and elaboration.
by: Altman, D, et al.
Published: (2001)

Social Rights and Deontological Constraints
by: Eduardo Rivera-López
Published: (2019-01-01)

The Right to a Fair Trial in the Area of Russian and Austrian Public Law
by: D. T. Karamanukyan, et al.
Published: (2022-04-01)

Clinical trial registry initiative
by: Laurence J Hirsch
Published: (2006-04-01)

SPIRIT 2013: new guidance for content of clinical trial protocols.
by: Chan, A, et al.
Published: (2013)

Public-private partnerships influencing the initiation and duration of clinical trials for neglected tropical diseases.
by: Zhongxuan Ma, et al.
Published: (2023-11-01)

Advancing the use of mobile technologies in clinical trials: recommendations from the clinical trials transformation initiative
by: Coran, P, et al.
Published: (2019)

Epidemiology of recent randomised controlled trials
by: Chan, A, et al.
Published: (2003)

Public administration: constraint & reality in public management
by: 350085 Lerner, A.
Published: (1991)

Allocation concealment in clinical trials.
by: Schulz, K, et al.
Published: (2002)

Prioritization and integration of lean initiatives with theory of constraints
by: Schwain, Kevin D. (Kevin Douglas), 1974-
Published: (2006)

The evolution of assessing bias in Cochrane systematic reviews of interventions: celebrating methodological contributions of the Cochrane Collaboration.
by: Turner, L, et al.
Published: (2013)

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.
by: Higgins, J, et al.
Published: (2011)

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
by: Higgins, J, et al.
Published: (2011)

Clinical trials initiative: patients or patents?
by: Gary Humphreys
Published: (2006-10-01)

Clinical trials initiative: patients or patents?
by: Gary Humphreys
Published: (2006-07-01)

CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.
by: Moher, D, et al.
Published: (2012)

CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.
by: Moher, D, et al.
Published: (2010)

CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials.
by: Moher, D, et al.
Published: (2010)

CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.
by: Moher, D, et al.
Published: (2010)

CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials
by: Moher, D, et al.
Published: (2012)